|
1
|
Manoharan I, Suryawanshi A, Hong Y,
Ranganathan P, Shanmugam A, Ahmad S, Swafford D, Manicassamy B,
Ramesh G, Koni PA, et al: Homeostatic PPARα signaling limits
inflammatory responses to commensal microbiota in the intestine. J
Immunol. 196:4739–4749. 2016.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Riaz F, Wei P and Pan F: PPARs at the
crossroads of T cell differentiation and type 1 diabetes. Front
Immunol. 14(1292238)2023.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Balakumar P, Rohilla A and Mahadevan N:
Pleiotropic actions of fenofibrate on the heart. Pharmacol Res.
63:8–12. 2011.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Kodama M, Matsumoto Y, Fujiwara M, Masani
F, Izumi T and Shibata A: A novel experimental model of giant cell
myocarditis induced in rats by immunization with cardiac myosin
fraction. Clin Immunol Immunopathol. 57:250–262. 1990.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Zhong C, Wu Y, Chang H, Liu C, Zhou L, Zou
J and Qi Z: Effect of PKC inhibitor on experimental autoimmune
myocarditis in Lewis rats. Oncotarget. 8:54187–54198.
2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Zhong C, Chang H, Wu Y, Zhou L, Wang Y,
Wang M, Wu P, Qi Z and Zou J: Up-regulated Cx43 phosphorylation at
Ser368 prolongs QRS duration in myocarditis. J Cell Mol Med.
22:3537–3547. 2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Cheng H, Xi Y, Chi X, Wu Y and Liu G:
Fenofibrate treatment of rats with experimental autoimmune
myocarditis by alleviating Treg/Th17 disorder. Cent Eur J Immunol.
41:64–70. 2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Maruyama S, Kato K, Kodama M, Hirono S,
Fuse K, Nakagawa O, Nakazawa M, Miida T, Yamamoto T, Watanabe K and
Aizawa Y: Fenofibrate, a peroxisome proliferator-activated receptor
alpha activator, suppresses experimental autoimmune myocarditis by
stimulating the interleukin-10 pathway in rats. J Atheroscler
Thromb. 9:87–92. 2002.PubMed/NCBI View
Article : Google Scholar
|
|
9
|
Chang H, Zhao F, Xie X, Liao Y, Song Y,
Liu C, Wu Y, Wang Y, Liu D, Wang Y, et al: PPARα suppresses Th17
cell differentiation through IL-6/STAT3/RORγt pathway in
experimental autoimmune myocarditis. Exp Cell Res. 375:22–30.
2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Chang H, Wang Y, Wu Y, Ma P, Song Y, Liu
C, Ye Y, Qi JH and Qi Z: Cardiac apoptosis caused by elevated
cholesterol level in experimental autoimmune myocarditis. Exp Cell
Res. 395(112169)2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Feng Y, Chen Z, Xu Y, Han Y, Jia X, Wang
Z, Zhang N and Lv W: The central inflammatory regulator IκBζ:
Induction, regulation and physiological functions. Front Immunol.
14(1188253)2023.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Hövelmeyer N, Schmidt-Supprian M and
Ohnmacht C: NF-κB in control of regulatory T cell development,
identity, and function. J Mol Med (Berl). 100:985–995.
2022.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Kakiuchi N, Yoshida K, Uchino M, Kihara T,
Akaki K, Inoue Y, Kawada K, Nagayama S, Yokoyama A, Yamamoto S, et
al: Frequent mutations that converge on the NFKBIZ pathway in
ulcerative colitis. Nature. 577:260–265. 2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Choi MC, MaruYama T, Chun CH and Park Y:
Alleviation of murine osteoarthritis by cartilage-specific deletion
of IκBζ. Arthritis Rheumatol. 70:1440–1449. 2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Bambouskova M, Gorvel L, Lampropoulou V,
Sergushichev A, Loginicheva E, Johnson K, Korenfeld D, Mathyer ME,
Kim H, Huang LH, et al: Electrophilic properties of itaconate and
derivatives regulate the IκBζ-ATF3 inflammatory axis. Nature.
556:501–504. 2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Slowikowski K, Nguyen HN, Noss EH, Simmons
DP, Mizoguchi F, Watts GFM, Gurish MF, Brenner MB and Raychaudhuri
S: CUX1 and IκBζ (NFKBIZ) mediate the synergistic inflammatory
response to TNF and IL-17A in stromal fibroblasts. Proc Natl Acad
Sci USA. 117:5532–5541. 2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Rao X, Huang X, Zhou Z and Lin X: An
improvement of the 2ˆ(-delta delta CT) method for quantitative
real-time polymerase chain reaction data analysis. Biostat
Bioinforma Biomath. 3:71–85. 2013.PubMed/NCBI
|
|
18
|
Bansal T, Chatterjee E, Singh J, Ray A,
Kundu B, Thankamani V, Sengupta S and Sarkar S: Arjunolic acid, a
peroxisome proliferator-activated receptor α agonist, regresses
cardiac fibrosis by inhibiting non-canonical TGF-β signaling. J
Biol Chem. 292:16440–16462. 2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Yamazaki S: The nuclear NF-κB regulator
IκBζ: Updates on its molecular functions and pathophysiological
roles. Cells. 13(1467)2024.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Hawkes JE, Yan BY, Chan TC and Krueger JG:
Discovery of the IL-23/IL-17 signaling pathway and the treatment of
psoriasis. J Immunol. 201:1605–1613. 2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Park A and Heo TH: IL-17A-targeting
fenofibrate attenuates inflammation in psoriasis by inducing
autophagy. Life Sci. 326(121755)2023.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Elaidy SM, Essawy SS, Hussain MA,
El-Kherbetawy MK and Hamed ER: Modulation of the IL-23/IL-17 axis
by fenofibrate ameliorates the ovalbumin/lipopolysaccharide-induced
airway inflammation and bronchial asthma in rats. Naunyn
Schmiedebergs Arch Pharmacol. 391:309–321. 2018.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Cao JW, Duan SY, Zhang HX, Chen Y and Guo
M: Zinc deficiency promoted fibrosis via ROS and TIMP/MMPs in the
myocardium of mice. Biol Trace Elem Res. 196:145–152.
2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Zhang Y, Ji H, Qiao O, Li Z, Pecoraro L,
Zhang X, Han X, Wang W, Zhang X, Man S, et al: Nanoparticle
conjugation of ginsenoside Rb3 inhibits myocardial fibrosis by
regulating PPARα pathway. Biomed Pharmacother.
139(111630)2021.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Qiu Z, Zhao Y, Tao T, Guo W, Liu R, Huang
J and Xu G: Activation of PPARα ameliorates cardiac fibrosis in
Dsg2-deficient arrhythmogenic cardiomyopathy. Cells.
11(3184)2022.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Bertelsen T, Ljungberg C, Litman T,
Huppertz C, Hennze R, Rønholt K, Iversen L and Johansen C: IκBζ is
a key player in the antipsoriatic effects of secukinumab. J Allergy
Clin Immunol. 145:379–90. 2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Gautam P, Maenner S, Cailotto F, Reboul P,
Labialle S, Jouzeau JY, Bourgaud F and Moulin D: Emerging role of
IκBζ in inflammation: Emphasis on psoriasis. Clin Transl Med.
12(e1032)2022.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Bertelsen T, Iversen L and Johansen C: The
human IL-17A/F heterodimer regulates psoriasis-associated genes
through IκBζ. Exp Dermatol. 27:1048–1052. 2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Mok BR, Kim AR, Baek SH, Ahn JH, Seok SH,
Shin JU and Kim DH: PFN1 prevents psoriasis pathogenesis through
IκBζ regulation. J Invest Dermatol. 142:2455–2463.e9.
2022.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Mills KHG: IL-17 and IL-17-producing cells
in protection versus pathology. Nat Rev Immunol. 23:38–54.
2023.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Ohto-Ozaki H, Hayakawa M, Kamoshita N,
Maruyama T, Tominaga SI and Ohmori T: Induction of IκBζ augments
cytokine and chemokine production by IL-33 in mast cells. J
Immunol. 204:2033–2042. 2020.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Yamamoto M, Yamazaki S, Uematsu S, Sato S,
Hemmi H, Hoshino K, Kaisho T, Kuwata H, Takeuchi O, Takeshige K, et
al: Regulation of Toll/IL-1-receptor-mediated gene expression by
the inducible nuclear protein IkappaBzeta. Nature. 430:218–222.
2004.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Lorscheid S, Müller A, Löffler J, Resch C,
Bucher P, Kurschus FC, Waisman A, Schäkel K, Hailfinger S,
Schulze-Osthoff K and Kramer D: Keratinocyte-derived IκBζ drives
psoriasis and associated systemic inflammation. JCI Insight.
4(e130835)2019.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Muromoto R, Sato A, Komori Y, Nariya K,
Kitai Y, Kashiwakura JI and Matsuda T: Regulation of NFKBIZ gene
promoter activity by STAT3, C/EBPβ, and STAT1. Biochem Biophys Res
Commun. 613:61–66. 2022.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Wang J, Liu T, Chen X, Jin Q, Chen Y,
Zhang L, Han Z, Chen D, Li Y, Lv Q and Xie M: Bazedoxifene
regulates Th17 immune response to ameliorate experimental
autoimmune myocarditis via inhibition of STAT3 activation. Front
Pharmacol. 11(613160)2021.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Zhou Z, Sun W, Liang Y, Gao Y, Kong W,
Guan Y, Feng J and Wang X: Fenofibrate inhibited the
differentiation of T helper 17 cells in vitro. PPAR Res.
2012(145654)2012.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Muromoto R, Tawa K, Ohgakiuchi Y, Sato A,
Saino Y, Hirashima K, Minoguchi H, Kitai Y, Kashiwakura JI, Shimoda
K, et al: IκB-ζ expression requires both TYK2/STAT3 activity and
IL-17-regulated mRNA stabilization. Immunohorizons. 3:172–185.
2019.PubMed/NCBI View Article : Google Scholar
|
